Suchergebnisse - "Othman, Ahmed A"

PubPharm (30)

1

Utility of Modeling and Simulation Approach to Support the Clinical Relevance of Dissolution Specifications : a Case Study from Upadacitinib Development

enthalten in: The AAPS journal | 2022

von Mohamed, M. | Winzenborg, I. | Othman, A. | +1

2

Effect of Upadacitinib on the Pharmacokinetics of Rosuvastatin or Atorvastatin in Healthy Subjects

enthalten in: Clinical pharmacology in drug development | 2021

von Mohamed, M. | Coppola, S. | Feng, T. | +3

3

Exposure-Response Analyses for Upadacitinib Efficacy in Subjects With Atopic Dermatitis-Analyses of Phase 2b Study to Support Selection of Phase 3 Doses

enthalten in: Journal of clinical pharmacology | 2021

von Mohamed, M. | Gopalakrishnan, S. | Teixeira, H. | +1

4

Characterization of the Effect of Upadacitinib on the Pharmacokinetics of Bupropion, a Sensitive Cytochrome P450 2B6 Probe Substrate

enthalten in: Clinical pharmacology in drug development | 2021

von Mohamed, M. | Minocha, M. | Trueman, S. | +4

5

Efficacy and safety of upadacitinib in Japanese patients with rheumatoid arthritis (SELECT-SUNRISE) : a placebo-controlled phase IIb/III study

enthalten in: Rheumatology (Oxford, England) | 2020

von Kameda, H. | Takeuchi, T. | Yamaoka, K. | +8

6

Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn's Disease

enthalten in: Gastroenterology | 2020

von Sandborn, W. | Feagan, B. | Loftus, E. | +19

CommentIn: Gastroenterology. 2021 Apr;160(5):1472-1474. - PMID 32311362

7

Efficacy of Upadacitinib in a Randomized Trial of Patients With Active Ulcerative Colitis

enthalten in: Gastroenterology | 2020

von Sandborn, W. | Ghosh, S. | Panes, J. | +9

CommentIn: Gastroenterology. 2021 Apr;160(5):1472-1474. - PMID 32311362

8

Clinical Pharmacokinetics of Upadacitinib : Review of Data Relevant to the Rheumatoid Arthritis Indication

enthalten in: Clinical pharmacokinetics | 2020

von Mohamed, M. | Klünder, B. | Othman, A.

9

Pharmacokinetics of Upadacitinib in Healthy Subjects and Subjects With Rheumatoid Arthritis, Crohn's Disease, Ulcerative Colitis, or Atopic Dermatitis : Population Analyses of Phase 1 and 2 Clinical Trials

enthalten in: Journal of clinical pharmacology | 2020

von Nader, A. | Stodtmann, S. | Friedel, A. | +2

10

Exposure-Response Analyses of Upadacitinib Efficacy and Safety in Phase II and III Studies to Support Benefit-Risk Assessment in Rheumatoid Arthritis

enthalten in: Clinical pharmacology and therapeutics | 2020

von Nader, A. | Mohamed, M. | Winzenborg, I. | +4